Examining Pediatric Cases From the Clinical Research Office of the Endourological Society Ureteroscopy Global Study

Basit Öğe Kaydı
dc.contributor.authorGuven, Selcuk
dc.contributor.authorBasiri, Abbas
dc.contributor.authorVarshney, Anil Kumar
dc.contributor.authorAridogan, Ibrahim Atilla
dc.contributor.authorMiura, Hiroyasu
dc.contributor.authorWhite, Mark
dc.contributor.authorKilinc, Mehmet
dc.date.accessioned2024-02-23T14:16:29Z
dc.date.available2024-02-23T14:16:29Z
dc.date.issued2017
dc.departmentNEÜen_US
dc.description.abstractOBJECTIVE To evaluate the characteristics and outcomes of ureteroscopy (URS) in children treated in several hospitals participating in the Clinical Research Office of the Endourological Society (CROES) Study, and to present the overall results of pediatric URS compared with adults. PATIENTS AND METHODS The CROES Study collected data on consecutive patients treated with URS for urolithiasis at each participating center over a 1-year period. The collected prospective global database includes data for 11,885 patients who received URS at 114 centers in 32 countries. Of these URStreated patients, 192 were <= 18 years old. RESULTS Of the 114 centers participating in the study, 42% had conducted pediatric URS. Among the pediatric cases, 7 were infants, 53 were small children, 59 were school-aged children, and 73 were adolescents. A considerable number (37%) of the pediatric cases had previously undergone URS treatment. No differences in the surgical outcomes of the adults and children were reported. The URS-treated children had a greater number of positive preoperative urine cultures when compared with adult cases treated. A semirigid scope was used in the vast majority of pediatric cases (85%). According to the present data, within the group of URS-treated children, the younger the child, the more readmissions occurred. CONCLUSION URS is as efficient and safe in children as it is in adults. The data suggest that readmissions among URS-treated children are associated with age, with the likelihood of readmissions greater among younger age groups. (C) 2016 Elsevier Inc.en_US
dc.description.sponsorshipBoston Scientificen_US
dc.description.sponsorshipThe CROES URS Global Study was supported by an unrestricted educational grant from Boston Scientific, which had no involvement in the design, collection, analysis, interpretation, or reporting of the data. Dr Nienke Wijnstok provided statistical support for the analyses reported.en_US
dc.identifier.doi10.1016/j.urology.2016.11.020
dc.identifier.endpage37en_US
dc.identifier.issn0090-4295
dc.identifier.issn1527-9995
dc.identifier.pmid27888151en_US
dc.identifier.scopus2-s2.0-85008311682en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage31en_US
dc.identifier.urihttps://doi.org/10.1016/j.urology.2016.11.020
dc.identifier.urihttps://hdl.handle.net/20.500.12452/12667
dc.identifier.volume101en_US
dc.identifier.wosWOS:000398958100012en_US
dc.identifier.wosqualityQ2en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherElsevier Science Incen_US
dc.relation.ispartofUrologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject[Keyword Not Available]en_US
dc.titleExamining Pediatric Cases From the Clinical Research Office of the Endourological Society Ureteroscopy Global Studyen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu